1992
DOI: 10.1016/s0015-0282(16)55435-1
|View full text |Cite
|
Sign up to set email alerts
|

Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

1995
1995
2015
2015

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(13 citation statements)
references
References 15 publications
0
13
0
Order By: Relevance
“…GH therapy does not, however, enhance gonadotrophic responsiveness in all women with infertility (Shaker et al 1992, Tapanainen et al 1992, Younis et al 1992. Most of the women that do respond to GH-hMG co-treatment have an impairment in their secretion of GH (Blumenfeld et al 1991).…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…GH therapy does not, however, enhance gonadotrophic responsiveness in all women with infertility (Shaker et al 1992, Tapanainen et al 1992, Younis et al 1992. Most of the women that do respond to GH-hMG co-treatment have an impairment in their secretion of GH (Blumenfeld et al 1991).…”
Section: Figurementioning
confidence: 99%
“…The infertility in these women may thus result in part from relative GH deficiency, whereas other dysfunctions are likely to be causal in the infertility of women that fail to respond to GH-hMG co-treatment (Blumenfeld et al 1991). GH responsiveness is also greatest in young, hypo-oestrogenic women who have been subjected to previous pituitary suppression (Shaker et al 1992, Tapanainen et al 1992, Younis et al 1992, Blumenfeld & Amit 1993. Conversely, GH therapy is largely ineffective in hypergonadotrophic women (Homburg & Farhi 1995) or women experiencing incipient or current ovarian failure (Homburg et al 1991).…”
Section: Figurementioning
confidence: 99%
“…Accordingly reduced age at menopause has been hypothesized for these women as a long-term consequence of having a smaller pool of primordial follicles [5]. In recent years, authors who have tried to define criteria for identifying POR have referred to variables such as: a peak E2 level of <300 pg/ml to <500 pg/ml [6,7], requirement for an increased daily [8] or total gonadotropin stimulation dose [9] or previous cancelled cycle due to a poor response [10]. Although the number of developing follicles and/or the number of oocytes retrieved after a standard dose of ovarian stimulation are two of the most frequent criteria used, the suggested cut-offs have often varied [7,11,12].…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, recent prospective studies have challenged the hypothesis that GH is involved in augmenting the ovarian responses to FSH in women [105][106][107][108]. In normal and poor responders undergoing IVF, neither follicular recruitment, E2 secretion by mature follicles, nor oocyte yield and quality are affected by GH treatment.…”
Section: Igf Responses During Ovulation Induction Igf I During Gh Trementioning
confidence: 99%
“…The lack of clinical efficiency of GH could result from the parallel increases in IGFBPs, along with IGF-I. The significant interpatient difference in the follicular fluid IGFBP responses to GH may additionally offer an explanation for the differences in clinical response to GH among published series [22, [92][93][94][105][106][107].…”
Section: Igf Responses During Ovulation Induction Igf I During Gh Trementioning
confidence: 99%